All In Biotech

Free tool

FAERS Monitor: Crestor

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021366 or its brand name (Crestor, Rosuvastatin Calcium). Reports on generic versions are filed under their own applications.

Reports

207,891

Serious

140,698

68% of reports

Hospitalization

64,548

Death reported

12,446

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue12,643
  • nausea10,873
  • diarrhoea10,009
  • drug ineffective9,957
  • dyspnoea9,810
  • off label use9,289
  • myalgia9,259
  • pain8,962
  • headache8,466
  • dizziness8,274
  • arthralgia7,767
  • asthenia7,654
  • pain in extremity7,094
  • malaise6,885
  • fall6,436

Reports by year received

View as table
YearReports
20042,921
20052,047
20063,055
20072,421
20083,898
20095,904
20107,391
20119,524
201211,040
20137,390
20148,106
201510,275
201610,288
20179,901
201811,123
201911,854
202011,540
202111,928
202212,119
202312,833
202413,919
202515,891
202612,523

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,846,268 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
myalgiaSignal9,2595.85.734,796
pain in extremitySignal7,0942.52.46,149
astheniaSignal7,6542.12.04,289
fall6,4362.01.93,087
arthralgia7,7671.91.93,353
dyspnoea9,8101.81.73,294
dizziness8,2741.71.72,346
fatigue12,6431.71.63,336
malaise6,8851.61.61,547
diarrhoea10,0091.61.52,150
pain8,9621.51.51,431
nausea10,8731.41.41,248
headache8,4661.41.3865
off label use9,2891.11.149
drug ineffective9,9570.80.7779

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.